ATANIS Biotech AG
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$2M
Company Overview
ATANIS Biotech AG is a biotechnology company that develops a novel, cell-based allergy diagnostic assay called FAST-PASE® to safely and accurately assess allergic reactions in a test tube.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATANIS Biotech AG Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ATANIS Biotech AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| Early Funding | Oct 22, 2024 | ||||
| Early Funding | Mar 28, 2023 |
Key People
Founding team and executive leadership
ATANIS Biotech AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AllerFund | Early Funding |
| Spectrum Moonshot Fund | Early Funding |
| iXLife Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Grew 21% QoQ, from 19 to 23 employees.
ATANIS Biotech AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ATANIS Biotech AG's valuation, stock price, and market status.